Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer

NCT: NCT07835087 · RECRUITING

NCT IDNCT07835087
StatusRECRUITING
Start Date2026-08-14
Completion2027-08-14
SponsorBeijing Friendship Hospital (OTHER)
First posted
Last updated

Brief Summary

This prospective, single-center, randomized controlled trial aims to evaluate the clinical effectiveness of an Image-Guided Platform assisted by a deep learning model for sentinel lymph node (SLN) retrieval in patients with early gastric cancer undergoing laparoscopic-endoscopic cooperative surgery combined with sentinel lymph node navigation surgery (LECS-SNNS). A total of 36 eligible participants will be randomly assigned in a 1:1 ratio to either the Image-Guided Platform group or the Traditional Palpation group. Both groups will undergo standardized indocyanine green fluorescence-guided sentinel lymphatic basin dissection and initial retrieval of fluorescent sentinel lymph nodes. In the experimental group, the remaining sentinel lymphatic basin (SLB) tissue will be examined using the Image-Guided Platform, which integrates radiographic and optical imaging with a deep learning model to identify and localize suspected lymph nodes. In the control group, LN retrieval will be performed using traditional visual inspection and palpation. The primary objective is to determine whether Image-Guided Platform-assisted LN retrieval increases the total number of SLNs retrieved intraoperatively compared with Traditional Palpation. Secondary objectives include assessment of LN retrieval efficiency, pathological findings, additional LN identification during permanent pathological examination, concordance between intraoperative frozen-section and permanent pathological examination, and other procedural, pathological, technical, and clinical outcomes relevant to the feasibility and performance of the Image-Guided Platform and deep learning model.

Frequently Asked Questions

What is Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer?

Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer is a clinical trial registered under NCT07835087. Current status: RECRUITING.

What is the status of NCT07835087?

The current status of NCT07835087 (Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer) is: RECRUITING.

When did Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer start?

Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer started on 2026-08-14.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.